CNZ-12016-16727
2 vaccinations
6 coded responses
26 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 201 / VA
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Registered in v-safe
-
2021-02-04
Dose 1 — Pfizer-BioNTech
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 1MedDRA: Conjunctival oedema — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I have had a return of chemosis in my left eye which has been occurring recently since I was diagnosed with and treated for Lymes disease back in November 2020.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Same problem as yesterday with eyes but appears to be getting better.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
-
2021-03-02
Dose 2 — Pfizer-BioNTech
- 2021-03-02
- 2021-03-03
-
2021-03-04
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Orbital myositis, Pre-existing disease — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Another flareup of orbital myositis mostly in my right eye.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Good · HeadacheFree text: same as yesterday but improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: Orbital myositis — Feeling: Fair · HeadacheFree text: Continued problem with orbital myositis but not as bad as beforeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
- 2021-03-23
-
2021-03-30
Survey response — day 28, dose 2MedDRA: Dizziness — Feeling: GoodFree text: Friday afternoon, every time I got up I almost passed out. I have no idea why.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-13
- 2021-06-01
- 2021-08-31
- 2022-03-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Pfizer-BioNTech | |
| 2 | 2021-03-02 | Pfizer-BioNTech |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): I have had a return of chemosis in my left eye which has been occurring recently since I was diagnosed with and treated for Lymes disease back in November 2020.
Systemic reaction (other): Same problem as yesterday with eyes but appears to be getting better.
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Another flareup of orbital myositis mostly in my right eye.
Systemic reaction (other): same as yesterday but improving
Systemic reaction (other): Continued problem with orbital myositis but not as bad as before
Release 6 — day 28, dose 2
Symptoms: Friday afternoon, every time I got up I almost passed out. I have no idea why.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | · | ✓ |
| SRO | Conjunctival oedema | ✓ | ✓ | ✓ |
| SRO | Orbital myositis | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release